{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:47:09Z","timestamp":1781790429389,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04534-y","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:02:33Z","timestamp":1725523353000},"page":"794-806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hereditary renal mass syndromes: a pictorial review"],"prefix":"10.1007","volume":"50","author":[{"given":"Acacia H.","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin R.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"issue":"1","key":"4534_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.ackd.2013.10.001","volume":"21","author":"NB Haas","year":"2014","unstructured":"Haas NB, Nathanson KL. Hereditary kidney cancer syndromes.\u00a0Adv Chronic Kidney Dis. 2014;21(1):81\u201390. https:\/\/doi.org\/10.1053\/j.ackd.2013.10.001","journal-title":"Adv Chronic Kidney Dis."},{"key":"4534_CR2","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Kidney Cancer V.1.2025. \u00a9 National Comprehensive Cancer Network, Inc. 2024. All rights reserved. Accessed [July 9, 2024]. To view the most recent and complete version of the guideline, go online to NCCN.org."},{"issue":"2","key":"4534_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/JU.0000000000001912","volume":"206","author":"SC Campbell","year":"2021","unstructured":"Campbell SC, Uzzo RG, Karam JA, Chang SS, Clark PE, Souter L. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow\u2013up: AUA Guideline: Part II. J Urol. 2021;206(2):209\u2013218. https:\/\/doi.org\/10.1097\/JU.0000000000001912","journal-title":"J Urol."},{"issue":"5","key":"4534_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, et al. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs\u2013Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2022;82(5):458\u2013468. https:\/\/doi.org\/10.1016\/j.eururo.2022.06.016","journal-title":"Eur Urol."},{"issue":"7","key":"4534_CR5","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00345-020-03441-3","volume":"39","author":"J Chahoud","year":"2021","unstructured":"Chahoud J, McGettigan M, Parikh N, et al. Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease.\u00a0World J Urol. 2021;39(7):2409\u20132415. https:\/\/doi.org\/10.1007\/s00345-020-03441-3","journal-title":"World J Urol."},{"key":"4534_CR6","unstructured":"van Leeuwaarde RS, Ahmad S, van Nesselrooij B, et al. Von Hippel\u2013Lindau Syndrome. 2000 May 17 [Updated 2024 Feb 29]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132024.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1463\/"},{"issue":"7","key":"4534_CR7","doi-asserted-by":"publisher","DOI":"10.1148\/rg.220209","volume":"43","author":"AS Shetty","year":"2023","unstructured":"Shetty AS, Fraum TJ, Ballard DH, et al. Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User's Guide. RadioGraphics. 2023;43(7):e220209. https:\/\/doi.org\/10.1148\/rg.220209","journal-title":"RadioGraphics."},{"issue":"2","key":"4534_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11912-009-0015-5","volume":"11","author":"CL Cowey","year":"2009","unstructured":"Cowey CL, Rathmell WK. VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy.\u00a0Curr Oncol Rep. 2009;11(2):94\u2013101. https:\/\/doi.org\/10.1007\/s11912-009-0015-5","journal-title":"Curr Oncol Rep."},{"issue":"1","key":"4534_CR9","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1159\/000320891","volume":"118","author":"BP Dixon","year":"2011","unstructured":"Dixon BP, Hulbert JC, Bissler JJ. Tuberous sclerosis complex renal disease.\u00a0Nephron Exp Nephrol. 2011;118(1):e15\u2013e20. https:\/\/doi.org\/10.1159\/000320891","journal-title":"Nephron Exp Nephrol."},{"issue":"7","key":"4534_CR10","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1148\/rg.2021210103","volume":"41","author":"MX Wang","year":"2021","unstructured":"Wang MX, Segaran N, Bhalla S, et al. Tuberous Sclerosis: Current Update.\u00a0RadioGraphics. 2021;41(7):1992\u20132010. https:\/\/doi.org\/10.1148\/rg.2021210103","journal-title":"RadioGraphics."},{"issue":"7","key":"4534_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","volume":"38","author":"P Yang","year":"2014","unstructured":"Yang P, Cornejo KM, Sadow PM, et al. Renal cell carcinoma in tuberous sclerosis complex.\u00a0Am J Surg Pathol. 2014;38(7):895\u2013909. https:\/\/doi.org\/10.1097\/PAS.0000000000000237","journal-title":"Am J Surg Pathol."},{"issue":"11","key":"4534_CR12","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","volume":"38","author":"J Guo","year":"2014","unstructured":"Guo J, Tretiakova MS, Troxell ML, et al. Tuberous sclerosis\u2013associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients.\u00a0Am J Surg Pathol. 2014;38(11):1457\u20131467. https:\/\/doi.org\/10.1097\/PAS.0000000000000248","journal-title":"Am J Surg Pathol."},{"key":"4534_CR13","unstructured":"Rout P, Zamora EA, Aeddula NR. Tuberous Sclerosis. [Updated 2024 May 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538492\/"},{"key":"4534_CR14","unstructured":"Sattler EC, Steinlein OK. Birt\u2013Hogg\u2013Dub\u00e9 Syndrome. In: Adam MP, Mirzaa GM, Pagon RA, et al., eds.\u00a0GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; February 27, 2006."},{"issue":"4","key":"4534_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/RCT.0000000000000409","volume":"40","author":"A Bhatnagar","year":"2016","unstructured":"Bhatnagar A, Rowe SP, Gorin MA, Pomper MG, Fishman EK, Allaf ME. Computed Tomography Appearance of Renal Hybrid Oncocytic\/Chromophobe Tumors.\u00a0J Comput Assist Tomogr. 2016;40(4):513\u2013516. https:\/\/doi.org\/10.1097\/RCT.0000000000000409","journal-title":"J Comput Assist Tomogr."},{"key":"4534_CR16","doi-asserted-by":"publisher","unstructured":"Lee E, Sayyouh M, Haggerty JE, Kazerooni E, Agarwal PP. Role of Radiologists in the Diagnosis of Unsuspected Birt\u2013Hogg\u2013Dub\u00e9 Syndrome in a Tertiary Clinical Practice. AJR Am J Roentgenol. 2019;213(4):792\u2013797. https:\/\/doi.org\/10.2214\/AJR.19.21176","DOI":"10.2214\/AJR.19.21176"},{"issue":"6","key":"4534_CR17","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.juro.2012.08.030","volume":"188","author":"CJ Ricketts","year":"2012","unstructured":"Ricketts CJ, Shuch B, Vocke CD, et al. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol. 2012;188(6):2063\u20132071. https:\/\/doi.org\/10.1016\/j.juro.2012.08.030","journal-title":"J Urol."},{"issue":"12","key":"4534_CR18","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","volume":"38","author":"AJ Gill","year":"2014","unstructured":"Gill AJ, Hes O, Papathomas T, et al. Succinate dehydrogenase (SDH)\u2013deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol. 2014;38(12):1588\u20131602. https:\/\/doi.org\/10.1097\/PAS.0000000000000292","journal-title":"Am J Surg Pathol."},{"issue":"5","key":"4534_CR19","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1148\/rg.2019180151","volume":"39","author":"SJ Withey","year":"2019","unstructured":"Withey SJ, Perrio S, Christodoulou D, et al. Imaging Features of Succinate Dehydrogenase\u2013deficient Pheochromocytoma\u2013Paraganglioma Syndromes.\u00a0RadioGraphics. 2019;39(5):1393\u20131410. https:\/\/doi.org\/10.1148\/rg.2019180151","journal-title":"RadioGraphics."},{"issue":"2","key":"4534_CR20","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.230063","volume":"6","author":"C Charbel","year":"2024","unstructured":"Charbel C, Causa Andrieu PI, Soliman M, et al. The Prevalence and Radiologic Features of Renal Cancers Associated with\u00a0FLCN, BAP1, SDH, and\u00a0MET\u00a0Germline Mutations.\u00a0Radiol Imaging Cancer. 2024;6(2):e230063. https:\/\/doi.org\/10.1148\/rycan.230063","journal-title":"Radiol Imaging Cancer."},{"issue":"6","key":"4534_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/gcc.22452","volume":"56","author":"CD Vocke","year":"2017","unstructured":"Vocke CD, Ricketts CJ, Merino MJ, et al. Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma. Genes Chromosomes Cancer. 2017;56(6):484\u2013492. https:\/\/doi.org\/10.1002\/gcc.22452","journal-title":"Genes Chromosomes Cancer."},{"key":"4534_CR22","doi-asserted-by":"publisher","unstructured":"Nikolovski I, Carlo MI, Chen YB, Vargas HA. Imaging features of fumarate hydratase\u2013deficient renal cell carcinomas: a retrospective study. Cancer Imaging. 2021;21(1):24. Published 2021 Feb 19. https:\/\/doi.org\/10.1186\/s40644-021-00392-9","DOI":"10.1186\/s40644-021-00392-9"},{"issue":"5","key":"4534_CR23","doi-asserted-by":"publisher","first-page":"1187.e1","DOI":"10.1016\/j.urology.2011.12.025","volume":"79","author":"JL Mester","year":"2012","unstructured":"Mester JL, Zhou M, Prescott N, Eng C. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome. Urology. 2012;79(5):1187.e1-1187.e11877.","journal-title":"Urology."},{"key":"4534_CR24","doi-asserted-by":"publisher","unstructured":"Tischkowitz M, Colas C, Pouwels S, Hoogerbrugge N; PHTS Guideline Development Group; European Reference Network GENTURIS. Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome. Eur J Hum Genet. 2020;28(10):1387\u20131393. https:\/\/doi.org\/10.1038\/s41431-020-0651-7","DOI":"10.1038\/s41431-020-0651-7"},{"issue":"9","key":"4534_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-13-0111","volume":"11","author":"MN Farley","year":"2013","unstructured":"Farley MN, Schmidt LS, Mester JL, et al. A novel germline mutation in BAP1 predisposes to familial clear\u2013cell renal cell carcinoma.\u00a0Mol Cancer Res. 2013;11(9):1061\u20131071. https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0111","journal-title":"Mol Cancer Res."},{"issue":"11","key":"4534_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/s41431-023-01448-z","volume":"31","author":"F Lalloo","year":"2023","unstructured":"Lalloo F, Kulkarni A, Chau C, et al. Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome. Eur J Hum Genet. 2023;31(11):1261\u20131269. https:\/\/doi.org\/10.1038\/s41431-023-01448-z","journal-title":"Eur J Hum Genet."},{"key":"4534_CR27","unstructured":"PDQ Cancer Genetics Editorial Board. Hereditary Papillary Renal Carcinoma (PDQ\u00ae): Health Professional Version. 2024 Feb 16. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002\u2013.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK568504\/"},{"key":"4534_CR28","doi-asserted-by":"publisher","unstructured":"Shen L, Yoon L, Mullane PC, Liang T, Tse JR. World Health Organization (WHO) 2022 Classification Update: Radiologic and Pathologic Features of Papillary Renal Cell Carcinomas.\u00a0Acad Radiol. Published online February 15, 2024. https:\/\/doi.org\/10.1016\/j.acra.2024.01.034","DOI":"10.1016\/j.acra.2024.01.034"},{"issue":"11","key":"4534_CR29","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1056\/NEJM197909133011107","volume":"301","author":"AJ Cohen","year":"1979","unstructured":"Cohen AJ, Li FP, Berg S, et al. Hereditary renal\u2013cell carcinoma associated with a chromosomal translocation. N Engl J Med. 1979;301(11):592\u2013595. https:\/\/doi.org\/10.1056\/NEJM197909133011107","journal-title":"N Engl J Med."},{"issue":"1","key":"4534_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/gcc.20718","volume":"49","author":"ER Woodward","year":"2010","unstructured":"Woodward ER, Skytte AB, Cruger DG, Maher ER. Population\u2013based survey of cancer risks in chromosome 3 translocation carriers.\u00a0Genes Chromosomes Cancer. 2010;49(1):52\u201358. https:\/\/doi.org\/10.1002\/gcc.20718","journal-title":"Genes Chromosomes Cancer."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04534-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04534-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04534-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:04:17Z","timestamp":1738645457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04534-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["4534"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04534-y","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Justin R Tse receives grant support from GE Healthcare and Bayer Healthcare, and is a consultant for Intuitive Surgical, Inc., AbSolutions Med, Inc., and Ascelia Pharma AB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}